Vishnu Chemicals Limited reported a consolidated net profit of ₹396.42 lakh for the first quarter ended June 30, 2026, marking a 23% increase from ₹322.25 lakh in Q1FY26. The Hyderabad-based specialty chemicals manufacturer saw its consolidated revenue from operations rise 25% year-on-year to ₹4,334.06 lakh, driven primarily by robust demand in international markets. The Board of Directors approved the unaudited financial results on August 01, 2026, following a limited review by statutory auditors Jampani & Associates.

Consolidated income from operations stood at ₹4,320.48 lakh, compared to ₹3,459.46 lakh in the prior-year quarter. Overseas sales surged 52% to ₹2,393.68 lakh, while domestic revenue grew modestly by 2% to ₹1,926.80 lakh. Total expenses increased to ₹3,911.85 lakh from ₹3,097.10 lakh, largely due to higher manufacturing and selling expenses. Profit before tax rose 32% to ₹550.98 lakh. The company’s basic and diluted earnings per share (EPS) were ₹5.89, up from ₹4.79 in Q1FY26.

Consolidated Financial Performance

On a standalone basis, Vishnu Chemicals reported a net profit of ₹318.52 lakh, a significant jump of 77% from ₹179.96 lakh in the corresponding quarter of FY26. Standalone revenue from operations grew 13% to ₹2,976.57 lakh. Overseas sales for the standalone entity increased 33% to ₹1,610.59 lakh, while domestic sales remained flat at ₹1,357.04 lakh. Standalone EPS rose to ₹4.73 from ₹2.67.

What the Numbers Show

The divergence between consolidated and standalone performance highlights the contribution of subsidiaries to overall profitability. While standalone revenue growth was moderate at 13%, consolidated revenue expanded by 25%, indicating that subsidiaries are driving top-line momentum. Furthermore, the 52% surge in consolidated overseas sales versus a 2% rise in domestic sales suggests a strategic shift or stronger demand in export markets. This geographic mix improvement is a key driver behind the margin expansion and profit growth observed in the quarter.

The financial results were prepared in accordance with Indian Accounting Standards (Ind AS) and reviewed pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Jampani & Associates, the statutory auditors, issued an unmodified opinion on both the standalone and consolidated statements. The audit committee reviewed the results before their approval by the Board.

Vishnu Chemicals Limited will host an analyst and institutional investor meeting on August 12, 2026, as part of the Emkay Confluence 2026 event in Mumbai. The company disclosed the schedule pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing shareholders and market participants of its engagement plans with financial intermediaries.

The meeting is scheduled to take place physically at the Emkay Confluence venue in Mumbai from 12:00 PM to 6:00 PM. Management intends to conduct both one-on-one discussions and group meetings with attending analysts and institutional investors. This engagement allows the company to communicate its operational updates and strategic outlook directly to key stakeholders.

The disclosure was submitted to BSE Limited and the National Stock Exchange of India Limited on July 29, 2026. Vibha Shinde, Company Secretary and Compliance Officer, signed the intimation, confirming adherence to regulatory norms for timely disclosure of such events.

Vishnu Chemicals Limited explicitly stated that no Unpublished Price Sensitive Information (UPSI) is proposed to be shared during the investor meeting. This assurance aligns with standard compliance practices to ensure fair information dissemination across all market participants. The company noted that changes to the schedule may occur due to exigencies from either party.

Engagement Details

The Emkay Confluence is a significant platform for corporate-investor interaction in India. By participating in this event, Vishnu Chemicals aims to maintain transparency and provide clarity on its business performance to the investment community. The format allows for detailed queries from analysts, facilitating a deeper understanding of the company’s financial health and future prospects among institutional holders.